Covered recipient · General Payments record
JOSEPH MARDELLI
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$2,294.32
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.78 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ethicon Inc. | $62.87 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.44 | 2 |
| HARMONY BIOSCIENCES LLC | $25.87 | 1 |
| GlaxoSmithKline, LLC. | $19.79 | 1 |
| Acerta Pharma LLC | $15.33 | 1 |
| ResMed Corp | $15.20 | 1 |
| Merck Sharp & Dohme Corporation | $13.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.33 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104635735 | CMS |
| Ethicon Inc. | $62.87 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077583814 | CMS |
| GlaxoSmithKline, LLC. | $19.79 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116293783 | CMS |
| HARMONY BIOSCIENCES LLC | $25.87 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126072717 | CMS |
| Merck Sharp & Dohme LLC | $13.28 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141633357 | CMS |
| Resmed Corp | $15.20 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140203576 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.34 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137629566 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.10 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137629568 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.